In Vitro Metabolism of (Nitrooxy)butyl Ester Nitric Oxide-Releasing Compounds: Comparison with Glyceryl Trinitrate
Open Access
- 1 May 2006
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 317 (2) , 752-761
- https://doi.org/10.1124/jpet.105.097469
Abstract
We investigated the in vitro metabolism of two (nitrooxy)butyl ester nitric oxide (NO) donor derivatives of flurbiprofen and ferulic acid, [1,1′-biphenyl]-4-acetic acid-2-fluoro-α-methyl-4-(nitrooxy)butyl ester (HCT 1026) and 3-(4-hydroxy-3-methoxyphenyl)-2-propenoic acid 4-(nitrooxy)butyl ester (NCX 2057), respectively, in rat blood plasma and liver subcellular fractions compared with (nitrooxy)butyl alcohol (NOBA) and glyceryl trinitrate (GTN). HCT 1026 and NCX 2057 undergo rapid ubiquitous carboxyl ester hydrolysis to their respective parent compounds and NOBA. The nitrate moiety of this latter is subsequently metabolized to inorganic nitrogen oxides (NOx), predominantly in liver cytosol by glutathione S-transferase (GST) and to a lesser extent in liver mitochondria. If, however, in liver cytosol, the carboxyl ester hydrolysis is prevented by an esterase inhibitor, the metabolism at the nitrate moiety level does not occur. In blood plasma, HCT 1026 and NCX 2057 are not metabolized to NOx, whereas a slow but sustained NO generation in deoxygenated whole blood as detected by electron paramagnetic resonance indicates the involvement of erythrocytes in the bioactivation of these compounds. Differently from NOBA, GTN is also metabolized in blood plasma and more quickly metabolized by different GST isoforms in liver cytosol. The cytosolic GST-mediated denitration of these organic nitrates in liver limits their interaction with other intracellular compartments to possible generation of NO and/or their subsequent availability and bioactivation in the systemic circulation and extrahepatic tissues. We show the possibility of modulating the activity of hepatic cytosolic enzymes involved in the metabolism of (nitrooxy)butyl ester compounds, thus increasing the therapeutic potential of this class of compounds.This publication has 32 references indexed in Scilit:
- Contribution of aldehyde dehydrogenase to mitochondrial bioactivation of nitroglycerin: evidence for the activation of purified soluble guanylate cyclase through direct formation of nitric oxideBiochemical Journal, 2005
- Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulationNature Medicine, 2003
- Role of Mitochondrial Aldehyde Dehydrogenase in Nitrate ToleranceMolecular Pharmacology, 2003
- Various intracellular compartments cooperate in the release of nitric oxide from glycerol trinitrate in liverBritish Journal of Pharmacology, 2003
- Pharmacology and potential therapeutic applications of nitric oxide‐releasing non‐steroidal anti‐inflammatory and related nitric oxide‐donating drugsBritish Journal of Pharmacology, 2002
- Identification of the enzymatic mechanism of nitroglycerin bioactivationProceedings of the National Academy of Sciences, 2002
- Reduction of organic nitrates catalysed by xanthine oxidoreductase under anaerobic conditionsBiochimica et Biophysica Acta (BBA) - General Subjects, 2001
- Relative role of heme nitrosylation and β-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulationProceedings of the National Academy of Sciences, 2000
- Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine.Proceedings of the National Academy of Sciences, 1993
- Possible involvement of S‐nitrosothiols in the activation of guanylate cyclase by nitroso compoundsFEBS Letters, 1980